memory

Novo Nordisk’s Phase 3 trials revealed that oral semaglutide failed to slow the progression of disease.

Cannabigerol relieved anxiety and stress without the psychoactive effects of THC in a small clinical trial.

Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.

Activating specific neurons using light helped scientists establish a causal link between improved sleep and diminished signs of Alzheimer’s disease in mice.

Researchers explore the role of forgetting in normal brain function and as a therapeutic target for fear-related disorders.

A dementia-associated tau mutation promotes unusual clustering of Fyn, a protein important for learning and memory.

Data from a highly resilient individual guided researchers to new potential therapeutic targets.  

Researchers identified a component of cerebrospinal fluid that improved memory in old mice, potentially opening the door to drug development.